NEW YORK (GenomeWeb) – Alere late Friday said that its shareholders approved the company's amended merger with Abbott.

About 63 million votes were in favor of the deal, representing more than 72.5 percent of all outstanding Alere shares as of the May 31 record date, the company said. Upon completion of the deal, Alere shareholders will receive $51 per share in cash.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.